Figure 1.
Immunohistochemical analysis of IFT80 in different types of gastric cancer. Expression of IFT80 was determined by immunohistochemical staining with an IFT80 antibody. (a) Gastric cancer tissue (type: malignant; pathology: adenocarcinoma; stage: II; TNM stage: T3N0M0; grade: 1) (200×). (b) Gastric cancer tissue (type: malignant; pathology: adenocarcinoma; stage: II; TNM stage: T3N0M0; grade: 2) (200×). (c) Gastric cancer tissue (type: malignant; pathology: adenocarcinoma; stage: IIIa; TNM stage: T3N1M0; grade: 3) (200×). (d) Gastric cancer tissue (type: malignant; pathology: adenocarcinoma; stage: IV; TNM stage: T3N3M0; grade: 3) (200×). (e) Gastric cancer tissue (type: malignant; pathology: adenocarcinoma; stage: IV; TNM stage: T3N3M0; grade: 3) (200×). (f) Gastric cancer tissue (type: malignant; pathology: papillary adenocarcinoma; stage: II; TNM stage: T3N0M0; grade: 2) (200×). (g) Normal gastric tissue (200×).